SKTO. Proprietary product Dharmanol hits the market with a bang. Problem will be manufacturing enough to meet demand of the consumers. So many other projects coming quickly. 600 million shares with massive revenues coming from over 400 collectives and the Pharmajanes website. Skies the limit.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.